热门资讯> 正文
Propanc Bizerma定价400万美元股票发行
2025-08-15 16:11
- Propanc Biopharma (OTCPK:PPCB) priced a public offering of 1M shares at $4 each, expecting $4M in gross proceeds to fund working capital and general purposes.
- In connection with the offering, the company has also granted the underwriter a 45-day option to purchase up to 150,000 additional shares of common stock.
- The company also received approval to list its common stock on the Nasdaq Capital Market, with trading set to start on August 15, 2025.
More on Propanc Biopharma, Inc.
- Financial information for Propanc Biopharma, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
